Medicaloid
Pharmaceutical

Gandhi medical college, peoples university to be part of Covaxin trial

BHOPAL: Two medical colleges in Bhopal, Gandhi Medical College (GMC) and Peoples University are to be part of Phase 3 trials of Covaxin— India’s indigenous Covid-19 vaccine developed in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The trial mooted by Telangana based, Bharat Biotech will be conducted in partnership with ICMR.

Phase 3 trials will involve 26,000 volunteers across 25 locations in India. The Clinical Trials Registry- India (CTRI) registered trial has been approved by the Drugs Controller General of India. It awaits approval of the institutional ethics committee of GMC and People’s university, according to CTRI.

Teams from ICMR and vaccine manufacture, conducted inspections at Gandhi Medical College and People’s Medical College in Bhopal. The countdown to the vaccine trial will begin as soon as the final agreement is made, said sources.

Follow and connect with us on , Facebook, Linkedin

Source link

Related posts

Oxford vaccine: Kiran Mazumdar-Shaw seeks quick regulatory processing after UK nod

Medicaloid

UConn startup DIANT bags license for continuous nanoparticle manufacturing tech

Medicaloid

Don’t turn Covid-19 into ‘political football’: WHO

Medicaloid